eo-adjuvant Progesterone and Vitamin D3 in Breast cancer
Phase 1
Completed
- Conditions
- Health Condition 1: null- Locally Advanced Breast Cancer and Large Operable Breast Cancer
- Registration Number
- CTRI/2013/06/003788
- Lead Sponsor
- Tata Memorial Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 800
Inclusion Criteria
Inclusion Criteria:
-Unilateral breast cancer
-Large operable breast cancer/LOBC (T3N0M0 or T3N1M0) and Locally advanced breast cancer/LABC (T3N1-2M0; T2N2M0)
-Age <70 years
-Fit for CT
Exclusion Criteria
Exclusion Criteria:
-Prior IB or EB
-Metastatic breast cancer
-Renal failure or deranged RFT
-Hypoparathyroidism
-Pregnant or lactating mothers or women of childbearing age not practicing contraception
-Patient on any of the following drugs: Magnesium-containing antacids, Digitalis, Phenytoin barbiturates, Thiazide diuretics.
-Previous history of other cancers except cured skin and cervical carcinoma in situ.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method